These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 35064455)
1. Tumor microenvironment and its clinicopathological and prognostic associations in surgically resected cutaneous angiosarcoma. Bi Y; Ge L; Ren X; Pang J; Zhao Y; Liang Z Clin Transl Oncol; 2022 May; 24(5):941-949. PubMed ID: 35064455 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment. Hoshimoto A; Tatsuguchi A; Hamakubo R; Nishimoto T; Omori J; Akimoto N; Tanaka S; Fujimori S; Hatori T; Shimizu A; Iwakiri K World J Gastroenterol; 2023 Oct; 29(40):5566-5581. PubMed ID: 37970475 [TBL] [Abstract][Full Text] [Related]
3. Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy. Dieci MV; Tsvetkova V; Griguolo G; Miglietta F; Tasca G; Giorgi CA; Cumerlato E; Massa D; Lo Mele M; Orvieto E; Guarneri V; Conte P Eur J Cancer; 2020 Sep; 136():7-15. PubMed ID: 32622323 [TBL] [Abstract][Full Text] [Related]
4. CD8⁺ tumor-infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma. Fujii H; Arakawa A; Utsumi D; Sumiyoshi S; Yamamoto Y; Kitoh A; Ono M; Matsumura Y; Kato M; Konishi K; Shiga T; Sano S; Sakaguchi S; Miyagawa-Hayashino A; Takahashi K; Uezato H; Miyachi Y; Tanioka M Int J Cancer; 2014 May; 134(10):2393-402. PubMed ID: 24243586 [TBL] [Abstract][Full Text] [Related]
5. Immune Checkpoint Markers in Superficial Angiosarcomas: PD-L1, PD-1, CD8, LAG-3, and Tumor-Infiltrating Lymphocytes. Googe PB; Flores K; Jenkins F; Merritt B; Moschos SJ; Grilley-Olson JE Am J Dermatopathol; 2021 Aug; 43(8):556-559. PubMed ID: 33156018 [TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of CD8-positive tumour-infiltrating lymphocytes and PD-L1 expression in salivary gland cancer. Kesar N; Winkelmann R; Oppermann J; Ghanaati S; Martin D; Neumayer T; Balster S; Rödel C; Rödel F; von der Grün J; Balermpas P Oral Oncol; 2020 Dec; 111():104931. PubMed ID: 32736208 [TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinicopathological significance of PD-L1 and tumor infiltrating lymphocytes in hypopharyngeal squamous cell carcinoma. Hu C; Tian S; Lin L; Zhang J; Ding H Oral Oncol; 2020 Mar; 102():104560. PubMed ID: 31923855 [TBL] [Abstract][Full Text] [Related]
8. Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC). Berghoff AS; Ricken G; Wilhelm D; Rajky O; Widhalm G; Dieckmann K; Birner P; Bartsch R; Preusser M J Neurooncol; 2016 Oct; 130(1):19-29. PubMed ID: 27436101 [TBL] [Abstract][Full Text] [Related]
9. Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer. Okabe M; Toh U; Iwakuma N; Saku S; Akashi M; Kimitsuki Y; Seki N; Kawahara A; Ogo E; Itoh K; Akagi Y Cancer Sci; 2017 Jan; 108(1):81-90. PubMed ID: 27801993 [TBL] [Abstract][Full Text] [Related]
10. CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma. Guo XJ; Lu JC; Zeng HY; Zhou R; Sun QM; Yang GH; Pei YZ; Meng XL; Shen YH; Zhang PF; Cai JB; Huang PX; Ke AW; Shi YH; Zhou J; Fan J; Chen Y; Yang LX; Shi GM; Huang XY Front Immunol; 2021; 12():705378. PubMed ID: 34526987 [TBL] [Abstract][Full Text] [Related]
11. PD-1/PD-L1 expression in a series of intracranial germinoma and its association with Foxp3+ and CD8+ infiltrating lymphocytes. Liu B; Arakawa Y; Yokogawa R; Tokunaga S; Terada Y; Murata D; Matsui Y; Fujimoto KI; Fukui N; Tanji M; Mineharu Y; Minamiguchi S; Miyamoto S PLoS One; 2018; 13(4):e0194594. PubMed ID: 29617441 [TBL] [Abstract][Full Text] [Related]
12. The predictive and prognostic value of Foxp3+/CD25+ regulatory T cells and PD-L1 expression in triple negative breast cancer. Zhang L; Wang XI; Ding J; Sun Q; Zhang S Ann Diagn Pathol; 2019 Jun; 40():143-151. PubMed ID: 31096176 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of tumor PD-L1 expression combined with CD8 Wang Q; Lou W; Di W; Wu X Int Immunopharmacol; 2017 Nov; 52():7-14. PubMed ID: 28846888 [TBL] [Abstract][Full Text] [Related]
14. Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer. Teng F; Meng X; Kong L; Mu D; Zhu H; Liu S; Zhang J; Yu J Transl Res; 2015 Dec; 166(6):721-732.e1. PubMed ID: 26209749 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma. Diana A; Wang LM; D'Costa Z; Allen P; Azad A; Silva MA; Soonawalla Z; Liu S; McKenna WG; Muschel RJ; Fokas E Oncotarget; 2016 Jul; 7(27):40992-41004. PubMed ID: 27329602 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Programmed Death Ligand 1 Expression and Tumor-Infiltrating Lymphocytes in Axial Osteosarcoma. Liu P; Xiao Q; Zhou B; Dai Z; Kang Y World Neurosurg; 2019 Sep; 129():e240-e254. PubMed ID: 31128313 [TBL] [Abstract][Full Text] [Related]
17. Programmed Death-Ligand 1 Expression and Tumor-Infiltrating Lymphocytes in Temporal Bone Squamous Cell Carcinoma. Hongo T; Kuga R; Miyazaki M; Komune N; Nakano T; Yamamoto H; Koike K; Sato K; Kogo R; Nabeshima K; Oda Y; Nakagawa T Laryngoscope; 2021 Dec; 131(12):2674-2683. PubMed ID: 34143491 [TBL] [Abstract][Full Text] [Related]
18. A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma. Tavares MC; Sampaio CD; Lima GE; Andrade VP; Gonçalves DG; Macedo MP; Cordeiro de Lima VC BMC Cancer; 2021 Aug; 21(1):901. PubMed ID: 34362334 [TBL] [Abstract][Full Text] [Related]
19. PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4 Mattox AK; Lee J; Westra WH; Pierce RH; Ghossein R; Faquin WC; Diefenbach TJ; Morris LG; Lin DT; Wirth LJ; Lefranc-Torres A; Ishida E; Chakravarty PD; Johnson L; Zeng YC; Chen H; Poznansky MC; Iyengar NM; Pai SI Cancer Res; 2017 Nov; 77(22):6365-6374. PubMed ID: 28947422 [TBL] [Abstract][Full Text] [Related]
20. Combined Evaluation of Tumor-Infiltrating CD8 + and FoxP3 + Lymphocytes Provides Accurate Prognosis in Stage IA Lung Adenocarcinoma. Kinoshita F; Takada K; Yamada Y; Oku Y; Kosai K; Ono Y; Tanaka K; Wakasu S; Oba T; Osoegawa A; Tagawa T; Shimokawa M; Oda Y; Mori M Ann Surg Oncol; 2020 Jun; 27(6):2102-2109. PubMed ID: 31773516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]